Matt joins Allele with 10 years of experience in the financial industry. Matt began his career working at Ipac Financial Planning, a specialty wealth management firm located in Hong Kong. Following Ipac, he worked for United Capital Financial Advisors, where he was responsible for both local and national growth initiatives. In 2016, Matt led initiatives at Noble Capital Markets focused on biotechnology and specialty pharmaceuticals equity research sales. Matt has developed a comprehensive network of institutional and accredited investors focused on life sciences. Matt is currently pursuing an MS in Biotechnology at Johns Hopkins University. He received a B.B.A in Entrepreneurship and a B.A. in Mathematics from Florida Atlantic University, where his honors thesis consisted of original research in the area of Graph Theory. Matt is a Level II CAIA candidate and holds FINRA Series 7 and 63 licenses.